NEPHROS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
NEPHROS, INC. (NEPH) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 2.47% for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2019-05-08
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2019-03-31 was 2.47%.
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2017-03-31 was 2.08%.
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2018 was 2.71%, a 23.74% increase from fiscal 2017.
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2017 was 2.19%, a 20.99% increase from fiscal 2016.
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2016 was 1.81%, a 13.13% increase from fiscal 2015.
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2015 was 1.60%, a 13.98% decline from fiscal 2014.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|
| 2019-03-31 | 2.47% 10-Q · filed 2019-05-08 | |||
| 2018-12-31 | 2.71% 10-K · filed 2019-03-12 | |||
| 2017-12-31 | 2.19% 10-K · filed 2019-03-12 | |||
| 2017-09-30 | 2.04% 10-Q · filed 2017-11-09 | |||
| 2017-06-30 | 2.04% 10-Q · filed 2017-08-08 | |||
| 2017-03-31 | 2.08% 10-Q · filed 2017-05-09 | |||
| 2016-12-31 | 1.81% 10-K · filed 2018-02-26 | |||
| 2015-12-31 | 1.60% 10-K · filed 2017-03-20 | |||
| 2015-09-30 | 1.55% 10-Q · filed 2015-11-10 | |||
| 2015-06-30 | 1.53% 10-Q · filed 2015-08-10 | |||
| 2014-12-31 | 1.86% 10-K · filed 2016-03-30 | |||
| 2013-12-31 | 1.36% 10-K · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |